The Cigna Group (NYSE:CI) Stock Position Boosted by Focused Investors LLC

Focused Investors LLC grew its stake in shares of The Cigna Group (NYSE:CI) by 8.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 587,450 shares of the health services provider’s stock after acquiring an additional 47,550 shares during the period. The Cigna Group comprises approximately 5.1% of Focused Investors LLC’s investment portfolio, making the stock its 8th biggest holding. Focused Investors LLC owned approximately 0.21% of The Cigna Group worth $162,218,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new stake in The Cigna Group in the fourth quarter worth about $51,589,000. AXQ Capital LP purchased a new position in The Cigna Group during the fourth quarter valued at approximately $422,000. Hillsdale Investment Management Inc. raised its stake in The Cigna Group by 4.4% in the fourth quarter. Hillsdale Investment Management Inc. now owns 2,390 shares of the health services provider’s stock worth $660,000 after buying an additional 100 shares in the last quarter. Mizuho Securities USA LLC lifted its holdings in The Cigna Group by 45.4% during the fourth quarter. Mizuho Securities USA LLC now owns 26,363 shares of the health services provider’s stock worth $7,280,000 after buying an additional 8,236 shares during the period. Finally, Quantbot Technologies LP boosted its position in The Cigna Group by 36.7% during the 4th quarter. Quantbot Technologies LP now owns 19,128 shares of the health services provider’s stock valued at $5,282,000 after acquiring an additional 5,137 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares of the company’s stock, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Noelle K. Eder sold 9,944 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the completion of the transaction, the insider now directly owns 13,406 shares of the company’s stock, valued at approximately $4,289,920. This represents a 42.59 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,751 shares of company stock worth $13,603,991. 0.60% of the stock is owned by insiders.

The Cigna Group Stock Down 1.4 %

The Cigna Group stock opened at $316.78 on Friday. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The firm has a market capitalization of $86.70 billion, a price-to-earnings ratio of 25.88, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The stock’s fifty day moving average is $300.83 and its two-hundred day moving average is $315.05. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the firm earned $6.79 earnings per share. Analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were paid a $1.51 dividend. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 1.91%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio is presently 49.35%.

Wall Street Analysts Forecast Growth

CI has been the subject of several analyst reports. Cantor Fitzgerald increased their price objective on The Cigna Group from $350.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday. UBS Group reduced their price target on The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Oppenheimer dropped their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. Stephens cut their price objective on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Finally, Wells Fargo & Company dropped their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and an average price target of $373.25.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.